2025 Revenue: $31.8 million, 34% YoY increase2025 Transaction Volumes of $960 million, 46% YoY increaseLaunch of Fold Bitcoin Credit Card and Enterprise ServicesRetired convertible notes, Streamlined capital for growth PHOENIX, March 17, 2026 (GLOBE NEWSWIRE) — Fold Holdings, Inc. (NASDAQ: FLD) (“Fold”, “we”, or “our”), the first publicly traded bitcoin financial services company, today announced financial results for the fourth quarter and full year ended December 31, 2025. FY 2025 Financial HighlightsRevenue: $31.8 million; 34% YoY increase Operating Loss: ($27.7) million Adjusted EBITDA2 (Loss): ($17.2) million Loss Per Share: ($1.65) per share Adjusted EBITDA (Loss) Per Share2: ($0.41) per share Bitcoin Investment Treasury Holdings1: 1,527 BTCFY 2025 Key Operating MetricsTotal Transaction Volume: $960 million; 46% YoY...

Record Backlog and Strategic DHS Win Accelerate Maritime Defense Platform Strategy MONROE TOWNSHIP, N.J., March 17, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT), today announced financial results, including record backlog, for its fiscal third quarter (“3Q26”) ended January 31, 2026. Highlights include: 3Q26 RESULTS and RECENT HIGHLIGHTSOPT secured a multi-buoy contract totaling approximately $6.5 million from the U.S. Department of Homeland Security (“DHS”) supporting a U.S. Coast Guard maritime domain awareness mission off San Diego. The award provides multi-quarter revenue visibility, with delivery of four newly built MERROWS®-equipped PowerBuoy® systems beginning in Q4 of fiscal 2026. The contract further advances our shift toward higher-margin,...

 Public release of Virbac Consolidated Accounts at 31 December 2025. The Group released its 2025 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”. The accounts were audited by the statutory auditors and examined by the board of directors on March 17, 2026. The report of the statutory auditors is in the process of being issued.AttachmentVirbac consolidated Accounts_31 December 2025

A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9%Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categories and countries. Volume/mix effect of ~+5%, completed by price increase of ~+3% Adjusted EBIT (before amortization of assets arising from acquisitions) margin of 16.3% at CERS despite:temporary shutdown of an antigen’s production site and higher inventory write-offs in FY25 partially offset by a solid underlying performance on sales prices and product mix and; improving operating expense to revenue ratio. Consolidated net income increased by +3.2% and amounts to €150.5m Strong cash generation of €93 million funded the Thyronorm acquisition while maintaining a relatively stable net debt at €172.8 million compared to €168.5 million at the end of...

                                                                         COMPAGNIE DE L’ODETResults for fiscal year 2025 March 17, 2026  Net profit, Group share: €218 million Proposal to pay a dividend of €4.80 per share, an increase of 9% Revenue: €2,924 million, -9% at constant scope and exchange rates. Adjusted operating income (EBITA (1) (2)): €282 million including the results of the equity-accounted associates UMG, Canal+, Louis Hachette Group, Havas and Vivendi for the full year 2025. Net income: €354 million, compared with €1,750 million in 2024, which included the net capital gain on the disposal of Bolloré Logistics (+€3.7 billion) and the capital loss on the deconsolidation of companies resulting from the spin-off of Vivendi (-€1.9 billion). Net income, Group share: €218 million. Net cash position: €5,126 million...

Nanterre, 17 March 2026 VINCI Autoroutes and VINCI Airports traffic in February 2026 I-      Change in VINCI Autoroutes’ intercity networks traffic  February YTD at the end of February (2 months)  % change 2026/2025 % change 2026/2025VINCI Autoroutes -0.8% -1.4%Light vehicles -1.2% -1.7%Heavy vehicles +1.1% +0.1%The decline in light vehicle traffic in February is due to the different positioning of school holidays compared to previous year and to unfavourable weather conditions. This has been partially offset by an increase in heavy vehicle traffic. Since the start of the year, total traffic has fallen by 1.4%, although it should be noted that January and February are traditionally not representative of the annual trend. II-      Change in VINCI Airports passenger traffic1  February YTD at the end of February (2...

              Results for fiscal year 2025 March 17, 2026Net income, Group share: €348 million Proposed ordinary dividend of €0.08 and exceptional dividend of €1.5 per share Revenue: €2,926 million, -9% at constant scope and exchange rates. Adjusted operating income (EBITA(1) (2)): €286 million including the results of the equity-accounted associates UMG, Canal+, Louis Hachette Group, Havas and Vivendi for the full year 2025. Net income: €351 million, compared with €1,840 million in 2024, which included the net capital gain on the disposal of Bolloré Logistics (+€3.6 billion) and the capital loss on the deconsolidation of companies resulting from the spin-off of Vivendi (-€1.9 billion). Net income, Group share: €348 million. Net cash position: €5,619 million at December 31, 2025 (compared with €5,306 million...

FY 2025 Sales Growth of 72% to $9.7 Million Driven by Strong Demand for Battery Products, Accessories and Technologies Next Generation Products for Industrial and Construction Applications to Expand Market Opportunities REDMOND, Ore., March 17, 2026 (GLOBE NEWSWIRE) — Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), an industry leader in lithium iron phosphate (“LiFePO4”) battery power storage solutions, today reported its financial and operational results for the fourth quarter and year ended December 31, 2025. Year Ended 2025 and Subsequent Financial and Operational HighlightsNet sales for the year ended December 31, 2025 totaled $9.7 million, a 72% increase compared to $5.6 million for the same period in 2024. Gross profit for the year ended December 31, 2025 totaled $1.3 million, a 16% increase compared to $1.2...

Record quarterly revenue in fourth quarter of $28.9M, +58% year-over-year growth; IFRS gross margin of 75.6% Fourth quarter pulse recurring revenue of $13.2M, +83% year-over-year growth Full fiscal year 2025 revenue of $87.6M, +47% year-over-year growth; IFRS gross margin of 75.3% Company achieves net profitability with full fiscal year 2025 IFRS and non-IFRS net income of $5.5M and $7.8M, respectively, versus a net loss of $4.5M and $2.1M, respectively, in the same period last year Approximately 2,700 Sofwave systems sold to date and more than 770,000 Sofwave treatments administered since commercialization Installed base continues to expand globally with systems placed across more than 50 countriesSAN CLEMENTE, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based...

Positive initial data reported from Phase 1a Single Ascending Dose study in nAMD in December 2025; preliminary data from ongoing Phase 1b/2 study expected in 1H 2027 Intend to initiate Phase 3 clinical trials by year-end 2027 Completed oversubscribed $50.0 million private placement in December 2025 $118.0 million in cash, cash equivalents and marketable securities as of December 31, 2025 is expected to fund operations into the fourth quarter of 2027 and through key clinical milestones BERKELEY HEIGHTS, N.J., March 17, 2026 (GLOBE NEWSWIRE) — Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced financial results for the full year ended December 31, 2025 and provided business...